Theravance Biopharma Files 8-K on Shareholder Vote Matters
Ticker: TBPH · Form: 8-K · Filed: May 20, 2025 · CIK: 1583107
| Field | Detail |
|---|---|
| Company | Theravance Biopharma, Inc. (TBPH) |
| Form Type | 8-K |
| Filed Date | May 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
Theravance Biopharma is holding a shareholder vote on important matters.
AI Summary
Theravance Biopharma, Inc. filed an 8-K on May 20, 2025, reporting on a submission of matters to a vote of security holders. The filing date for the report is May 19, 2025. The company is incorporated in the Cayman Islands and its principal executive offices are located in South San Francisco, CA.
Why It Matters
This filing indicates that Theravance Biopharma is engaging in a process that requires shareholder approval, which could impact corporate governance and future strategic decisions.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not an event that inherently carries significant financial risk.
Key Players & Entities
- Theravance Biopharma, Inc. (company) — Registrant
- May 19, 2025 (date) — Date of earliest event Reported
- May 20, 2025 (date) — Date of Report
- Cayman Islands (location) — State or Other Jurisdiction of Incorporation
- South San Francisco, CA (location) — Principal Executive Offices
FAQ
What specific matters are being submitted to a vote of security holders?
The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 19, 2025.
What is the Commission File Number for Theravance Biopharma, Inc.?
The Commission File Number is 001-36033.
Where are Theravance Biopharma's principal executive offices located?
The principal executive offices are located at C/O Theravance Biopharma US, LLC, 901 Gateway Boulevard, South San Francisco, CA 94080.
What is the Standard Industrial Classification (SIC) code for Theravance Biopharma, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 20, 2025 regarding Theravance Biopharma, Inc. (TBPH).